Edition:
United Kingdom

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

30.91EUR
18 Jan 2019
Change (% chg)

€0.16 (+0.52%)
Prev Close
€30.75
Open
€31.00
Day's High
€31.24
Day's Low
€30.62
Volume
465,021
Avg. Vol
396,575
52-wk High
€38.78
52-wk Low
€27.49

Latest Key Developments (Source: Significant Developments)

Recordati: Confirms 2018 And Announces 2019 Targets
Friday, 21 Dec 2018 

Dec 21 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::CONFIRMS 2018 AND ANNOUNCES 2019 TARGETS .SEES 2019 REVENUE BETWEEN EUR 1.430 MILLION AND EUR 1.450 MILLION.SEES 2019 EBITDA OF EUR 520-530 MILLION.SEES 2019 NET PROFIT OF EUR 330-335 MILLION.MAJORITY OF BOARD DOES NOT DEEM PRICE PER SHARE OF EUR 27.55 IN TENDER OFFER ON COMPANY ADEQUATE.  Full Article

Recordati Signs Agreement With Helsinn For Exclusive Commercialization Rights To Ledaga
Thursday, 20 Dec 2018 

Dec 20 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::SIGNS AGREEMENT WITH HELSINN FOR EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA.AGREEMENT GRANTS ORPHAN EUROPE RIGHTS WORLDWIDE, EXCLUDING UNITED STATES, CHINA, HONG KONG AND ISRAEL.LEDAGA IS INDICATED FOR TOPICAL TREATMENT OF MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA.  Full Article

CVC Capital Partners Launches Through Rossini Investimenti Takeover Bid On Recordati
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::FOLLOWING INDIRECT ACQUISITION OF 51.8 PERCENT STAKE IN RECORDATI, ROSSINI INVESTIMENTI LAUNCHES TAKEOVER BID.ROSSINI INVESTIMENTI IN INDIRECTLY CONTROLLED BY CVC CAPITAL PARTNERS VII LIMITED.ROSSINI INVESTIMENTI TO PAY 27.55 EUROS PER EACH TENDERED SHARE.TAKEOVER OFFER IS NOT FINALIZED AT DELISTING THE COMPANY.ROSSINI INVESTIMENTI RESERVES RIGHT TO DECIDE WHETHER TO RESTORE FREE FLOAT IF IT REACHES THRESHOLD BETWEEN 90 AND 95 PERCENT.  Full Article

Recordati Q3 Net Profit At EUR 73.7 Mln, To Distribute Interim Dividend Of EUR 0.45 /shr
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::Q3 REVENUE EUR 317.3 MILLION VERSUS EUR 313.0 MILLION YEAR AGO.Q3 NET PROFIT EUR 73.7 MILLION VERSUS EUR 72.8 MILLION YEAR AGO.TO DISTRIBUTE INTERIM DIVIDEND OF EUR 0.45 PER SHARE.CEO SAYS EXPECTS FOR THE WHOLE OF 2018 TO ACHIEVE SALES RANGING FROM €1,340 MILLION TO €1,350 MILLION.CEO SAYS CO CONFIRMS OBJECTIVES FOR EBITDA OF BETWEEN €490 AND €500 MILLION.CEO SAYS CO CONFIRMS OBJECTIVES FOR NET INCOME OF BETWEEN €310 AND €315 MILLION.  Full Article

Recordati H1 Net Profit up at Eur 164.2 Mln
Thursday, 26 Jul 2018 

July 26 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::H1 REVENUE EUR 696.1 MILLION VERSUS EUR 650.9 MILLION YEAR AGO.H1 NET PROFIT EUR 164.2 MILLION VERSUS EUR 147.0 MILLION YEAR AGO.CEO SAYS CO CONFIRMS TARGETS FOR FY 2018.  Full Article

Fimei Says Agreement For Sale Of Stake To CVC Values Recordati At EUR 28 /shr With Dividend
Monday, 2 Jul 2018 

July 2 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::FIMEI SAYS AGREEMENT FOR SALE OF FIMEI STAKE TO CVC CAPITAL PARTNERS IMPLIES VALUE OF EUR 28 PER RECORDATI SHARE CUM DIVIDEND.  Full Article

CVC agrees to acquire FIMEI S.p.A. for about EUR 3 bln
Friday, 29 Jun 2018 

June 29 (Reuters) - :RECORDATI- FIMEI REACHED AN AGREEMENT TO SELL THEIR ENTIRE SHAREHOLDING IN FIMEI TO A CONSORTIUM OF INVESTMENT FUNDS CONTROLLED BY CVC CAPITAL PARTNERS.TRANSACTION CONSIDERATION UNDER AGREEMENT IS APPROXIMATELY EUR 3 BILLION, IMPLYING A PRICE OF EUR 28 PER RECORDATI S.P.A. SHARE.CONSIDERATION WILL BE PAYABLE AS APPROXIMATELY EUR 2.3 BILLION IN CASH AND EUR 750 MILLION IN SUBORDINATED LONG-TERM DEBT SECURITIES.COMPLETION OF SALE OF FIMEI IS ANTICIPATED TO TAKE PLACE IN LAST QUARTER OF 2018.AGREEMENT IS SUBJECT ONLY TO INVESTORS RECEIVING REQUIRED ANTI-TRUST AND COMPETITION CLEARANCES IN RELEVANT JURISDICTIONS.  Full Article

Recordati shares suspended from trading pending statement - bourse
Friday, 29 Jun 2018 

June 29 (Reuters) - Recordati::MILAN STOCK EXCHANGE SAYS RECORDATI SHARES ARE SUSPENDED FROM AFTER-HOURS TRADING PENDING STATEMENT.  Full Article

Fimei Confirms Negotiations With CVC For Sale Of Recordati By Recordati Family
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::FIMEI CONFIRMS THAT THERE ARE NEGOTIATIONS WITH CVC FUND FOR SALE BY RECORDATI FAMILY OF INDIRECT CONTROL OF RECORDATI.FIMEI ADDS THERE ARE 'MANY' OBSTACLES TO OVERCOME AND THERE IS NO CERTAINTY OVER PROSECUTION OF NEGOTIATIONS AND THEIR TIMING.  Full Article

Recordati Q1 Net Profit Up At EUR 86.6 Mln
Tuesday, 8 May 2018 

May 8 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::Q1 REVENUE EUR 366.5 MILLION VERSUS EUR 341.9 MILLION YEAR AGO.Q1 NET PROFIT EUR 86.6 MILLION VERSUS EUR 78.5 MILLION YEAR AGO.CONFIRMS 2018 TARGETS.  Full Article